The main purpose of this legislation, known as the Global Fairness in Drug Pricing Act, is to lower prescription drug prices in the United States by aligning them with prices in other developed countries. The goal is to ensure that American patients do not pay more for their medications than individuals in similar nations. Key provisions of the Act include several important measures. First, it requires the Secretary of Health and Human Services to propose a plan that sets price targets for pharmaceutical manufacturers, ensuring that drug prices in the U.S.